Press release
Recombinant Proteins for Basic Research to Surpass US$ 270 Mn Revenue by 2022-end
A new report published by Fact.MR estimates the global recombinant protein market to witness expansion at a moderate CAGR during the forecast period 2017 to 2022. Revenues from the global recombinant protein market will reach nearly US$ 460 Mn by 2022-end.Click here to Get Synopsis of the Report - https://www.factmr.com/report/186/recombinant-protein-market
Through genetic engineering, and cell engineering, recombinant protein are produced from creature body. The recombinant protein technology now stands at the edge of biotechnology production. Becoming the new standard, this technology is witnessing a gradual shift from bulk production procedure towards post-production techniques, which in turn promises an enhanced delivery and stability.
The highly effective recombinant proteins play an integral part in treating specific diseases, such as hemophilia. However, blood coagulation factor is excluded, as it possesses an extremely limited source. A large number of recombinant protein drugs utilized are human proteins. This is mainly to compensate functional proteins in vivo defects, and for increasing the functions of proteins in a body. These factors provide recombinant proteins with substantially higher safety as compared to small molecules, further leading towards higher approval rates.
For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=186
The clinical trial periods for recombinant proteins are comparatively shorter than small molecule drugs, which further aids in enhancing patient protection, and renders pharmaceutical companies with a relatively longer exclusive sales time. Factors such as these are driving the development, and demand for recombinant proteins.
Recombinant proteins target diseases such as cardiovascular diseases, endocrine diseases, viral diseases, and cancer. In addition, the global recombinant protein market has a larger extension space, with few approval drugs available without any alternative products in therapeutic areas. These factors might influence growth of the market over the forecast period.
However, factors such as technical barriers, financial barriers have made recombinant protein technology expensive. Moreover, replication of recombinant proteins incurs many challenges, as compared to replication of small molecule chemicals. These factors may impede growth of the market in the near future.
For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=186
10 Key Estimations on Future of Global Recombinant Protein Market
• Basic research will remain the largest application segment in the global recombinant proteins market. Revenues from basic research will reach roughly US$ 270 Mn in revenues by the end of 2022.
• Toxicity screening, and drug discovery & development will witness the fastest expansion through 2022, based on application of recombinant proteins.
• Recombinant protein sales for forensic testing application will exhibit the lowest CAGR in the market through 2022.
• North America is projected to remain dominant in the global market for recombinant proteins, with sales poised to account for approximately US$ 150 Mn revenues by 2022-end.
• Europe will continue to be the second largest market for recombinant proteins over the forecast period.
• The market for recombinant protein in Middle East & Africa (MEA) will exhibit a sluggish expansion through 2022.
• Academic & research institutes will remain the most lucrative end-users in the global recombinant proteins market, accounting for more than one-third revenue share of the market throughout the forecast period.
For in-depth competitive analysis, buy now - https://www.factmr.com/checkout/186/S
• Biopharmaceutical companies will continue to be the fastest expanding end-users of recombinant proteins in the global market.
• Although growth factors are estimated to remain the largest product segment, sales of chemokines will register the fastest expansion through 2022.
• Key players identified in the global recombinant protein market include Thermo Fisher Scientific, Inc., Sigma Aldrich, Merck Millipore Limited, GenScript Corporation, Crown Bioscience, Inc., PerkinElmer, Inc., BPS Bioscience Inc., Bio-Rad Laboratories, Inc., A.M.S. Biotechnology (Europe) Limited, and Abcam plc.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/186/recombinant-protein-market
Content Source: https://www.factmr.com/media-release/176/recombinant-protein-market
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Recombinant Proteins for Basic Research to Surpass US$ 270 Mn Revenue by 2022-end here
News-ID: 2265643 • Views: …
More Releases from Fact.MR
Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB L …
Digital Twin Market is valued at USD 5 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 34.3%, reaching USD 95 billion by 2033. This explosive growth is driven by the increasing adoption of digital twins across industries to optimize operations, reduce costs, and enhance decision-making through virtual replicas of physical assets. Digital twins integrate IoT, AI, and data analytics to simulate real-world…
Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 …
The global hemato oncology testing market is valued at USD 4.33 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 18.5%, reaching USD 23.64 billion by 2033. This rapid growth is driven by the increasing prevalence of blood-related cancers, such as lymphoma and leukemia, and advancements in diagnostic technologies like next-generation sequencing (NGS) and polymerase chain reaction (PCR). Hemato oncology testing plays a…
Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 203 …
Osseointegration Implants Market is poised for robust growth, with its valuation projected to rise from USD 3.17 billion in 2025 to USD 6.85 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8%. This expansion is driven by the increasing prevalence of orthopedic and dental disorders, such as osteoarthritis, rheumatoid arthritis, and edentulism, which necessitate advanced implant solutions. Osseointegration implants, which fuse directly with bone to provide stable…
Fibrin Sealants Market is Anticipated to Reach USD 1.92 Billion by 2033 | Fact.M …
The global fibrin sealants market is valued at USD 976.5 million in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 7%, reaching USD 1.92 billion by 2033. This growth is driven by the increasing prevalence of surgical procedures requiring effective hemostasis and tissue sealing, particularly in cardiovascular, orthopedic, and general surgeries. Fibrin sealants, derived from human plasma proteins, mimic the body's natural clotting process,…
More Releases for Unit
Global Transcutaneous Electrical Nerve Stimulation Unit Market, Transcutaneous E …
Global Transcutaneous Electrical Nerve Stimulation Unit Market Overview:
The Transcutaneous Electrical Nerve Stimulation Unit market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Transcutaneous Electrical Nerve Stimulation Unit market has experienced significant growth, driven by factors such as increasing consumer demand,…
Glycol Dehydration Unit Market Glycol Dehydration Unit Market 2028
Persistence Market Research delivers key insights on the global glycol dehydration unit market, in its report titled, 'Glycol Dehydration Unit Market: Global Industry Analysis 2013-2017 and Forecast 2018-2028'. Over the forecast years, the global glycol dehydration unit market is expected to show a positive outlook.
The market value is expected to increase at a healthy pace over the forecast period. Based on the glycol type segment, the triethylene glycol segment is…
Biodiesel Processing Unit
While reserves of petroleum are decreasing every passing day, energy consumption is increasing at 6.5% per annum. And for solving this issue many countries are implementing new policies for minimizing the usage of fossil fuels and increase the use of alternative sources like solar power and Biodiesel. Biodiesel is a diesel fuel substitute made from a variety of oils, fats, and greases which can become a cheaper alternative to fossil…
Jackfruit Processing Unit
The fruit processing sector has some undoubtedly potential Business Ideas, and Jackfruits processing is highly recommended because jackfruits are highly perishable tropical fruits, which helps in improving the immunity, replenishes the energy, cardiovascular health, regulates Blood Pressure, Digestion, treats the skin diseases, prevent/control asthma and many more awesome advantages of jackfruit consumption.
Rising demand for processed fruit product for secondary preparations, rising income, and resultant increased spending on food items is…
Pomegranate Processing unit
India is the second largest producer of Pomegranates in the world after Iran, still contributes only 5% pomegranate related international trades. India produces the finest edible Pomegranates, which are available almost throughout the year, which provides a tremendous potential for export of Pomegranate and its products from India.
Processing of the Pomegranates becomes essential in order to increase the utilization and reduce the wastage of the fruit. Pomegranates being rich in…
Coconut Processing Unit
Coconut is an important fruit in the Indian economy as the country is listed among the top Coconut producing countries in the world. The contribution of Coconut is about ₹27900 crore to India’s Gross Domestic Product (GDP).
Today's improved economic stability, spending power, nutritional requirements, and awareness are pushing consumers to shift their preferences.
Currently, Coconut water, Coconut milk/cream and Virgin Coconut Oil (VCO) are expected to be main growth drivers for…
